Skip to main content

Gayathri R. Devi

Adjunct Professor in the Department of Surgery
Surgery, Surgical Sciences
Box 2606 Med Ctr, Durham, NC 27710
477 Med.Sci.Res.Bldg. (MSRB1), 2606 DUMC, Durham, NC 27710

Overview


Dr. Devi’s research interests include functional genomics, anti-cancer drug discovery and development, mechanisms of cancer cell signaling, tumor immunity and applications thereof for overcoming therapeutic resistance in cancer.

The lab has established prostate, inflammatory breast cancer and ovarian cellular and tumor models.

Current Duke Appointments & Affiliations


Adjunct Professor in the Department of Surgery · 2026 - Present Surgery, Surgical Sciences, Surgery

Recent News Items


Published November 22, 2023
Urban Environmental Factors Driving Breast Cancer Incidence
Published January 9, 2019
Cancer Cells Steer a Jagged Path
Published March 28, 2017
Study Shows How BPA May Affect Inflammatory Breast Cancer

View All News Items

Recent Scholarly Works


Scientific highlights and perspectives from the International Inflammatory Breast Cancer Symposium 2025.

Journal article Cancer · May 15, 2026 Inflammatory breast cancer (IBC) is a rare yet highly aggressive subtype of breast cancer, characterized by distinct clinical features, rapid progression, and complex biology. Despite decades of research, patient outcomes remain poor, underscoring the need ... Full text Link to item Cite

Trust in researchers and willingness to engage in cancer research.

Journal article Oncologist · May 8, 2026 BACKGROUND: Trust in medical scientists shapes public engagement in health and biomedical research, yet its influence on cancer research participation is not well understood. This study assessed trust in researchers and examined its relationship with willi ... Full text Link to item Cite

The spatial immune landscape predicts outcome and reveals the central role of tumor-associated macrophages in inflammatory breast cancer biology.

Journal article Breast Cancer Res · January 5, 2026 BACKGROUND: Inflammatory breast cancer (IBC) is a rare but aggressive subtype of breast cancer characterized by rapid progression and poor prognosis. Despite its distinct clinical presentation and molecular features, the immune landscape of IBC and its pot ... Full text Link to item Cite
View All Scholarly Works

Recent Grants


Pharmacological Sciences Training Program

Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2025 - 2030

Molecular Determinants of Health Disparities in Inflammatory Breast Cancer

ResearchPrincipal Investigator · Awarded by National Cancer Institute · 2021 - 2026

View All Grants

Education


University of Nebraska, College of Medicine · 1998 Ph.D.